The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Related Articles
Tumor Treating Fields Extend OS for Patients With Locally Advanced Pancreatic Cancer
The addition of tumor treating fields to first-line chemotherapy can extend overall survival without increasing systemic toxicity among patients with locally advanced pancreatic cancer, according…
The OncoAlert Newsletter
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
The OncoAlert Newsletter
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
First-Line Sacituzumab Govitecan + Pembro Significantly Improves PFS Over Chemo + Pembro in PD-L1–Positive TNBC
According to results from the phase 3 ASCENT-04/KEYNOTE-D19 trial, sacituzumab govitecan plus pembrolizumab demonstrates a significant improvement in progression-free survival compared with chemotherapy plus pembrolizumab…
The OncoAlert Newsletter
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
The OncoAlert Newsletter
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
The OncoAlert Newsletter
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
Sylvester Comprehensive Cancer Center Recaps ASCO 2025 Participation – OncoDaily
Sylvester Comprehensive Cancer Center Recaps ASCO 2025 Participation / ASCO25, cancer, cancer care, OncoDaily, Oncology, Sylvester Comprehensive Cancer Center
JCO Global Oncology’s New Editor-In-Chief Dr. Katherine Van Loon to Champion Enhanced Access and Representation in Cancer Research
Dr. Katherine Van Loon is committed to addressing the increasing global cancer burden by elevating diverse voices and research focused on expanding access to cancer…